Cancer diagnostics company Pacific Edge (NZX/ASX: PEB) today notes that a draft Local Coverage Determination (LCD) with foundational medical policy for urine-based biomarkers for hematuria evaluation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results